Last update:

Medications news

Medications

Therapeutic-dose anticoagulation linked to lower mortality in COVID-19

For patients hospitalized for COVID-19, administration of therapeutic-dose versus prophylactic-dose anticoagulation with heparins is associated with lower 28-day mortality, according to a review published online Dec. 24 in ...

Medications

2020 to 2023 saw increase in buprenorphine dispensing for teens

Buprenorphine dispensing increased among adolescents and decreased among young adults between 2020 and 2023, according to a research letter published online Dec. 23 in the Journal of the American Medical Association.

Medications

Migraine relief: New drug may start working right away

A drug recently approved to prevent migraine may start working right away, according to a study published in the December 23, 2024, online issue of Neurology. The study looked at the drug atogepant, which is a calcitonin ...

Medications

Plant-based extract shows potential for psoriasis treatment

A research group has made significant progress in investigating the therapeutic effects and molecular mechanisms of stilbene-enriched extracts from the leaves of Cajanus cajan (L.) Millsp.(C. cajan) as a potential therapeutic ...

Medications

FDA expands approval of Vtama to include atopic dermatitis

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the topical treatment of atopic dermatitis in adult and pediatric patients aged 2 years and older.

Medications

FDA says shortage of GLP-1 tirzepatide is over

The U.S. Food and Drug Administration re-issued a decision first made by the agency in October that a shortage of the diabetes/weight-loss med tirzepatide is over.

Medications

Nucleic acid drug iSN40 shows promise for osteoporosis treatment

Osteoporosis, characterized by an imbalance in bone remodeling, is a growing health concern worldwide. Previous research has highlighted the role of osteogenic CpG oligodeoxynucleotide (iSN40) in promoting osteoblast differentiation ...

Medications

How do multiple sclerosis drugs affect pregnancy?

Many women are diagnosed with multiple sclerosis (MS) at an age when they are considering starting a family. What does the disease and its medication mean for the child? To answer this question, a research team headed by ...

Medications

Clopidogrel edges out aspirin in heart procedure recovery

Researchers at 37 sites in South Korea have found patients taking clopidogrel after percutaneous coronary intervention (PCI) experienced lower rates of both thrombotic and bleeding events than those taking aspirin. Clopidogrel's ...

Medications

Diabetes drug linked to increased risk of severe eye condition

Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, ...

Medications

St John's wort: Six drug interactions you should know about

St John's wort is an herbal supplement that has been used for centuries to boost mood. Even today, many people use it as a natural treatment for mild to moderate depression. St John's wort contains several active compounds, ...

Medications

Drug acoramidis to treat rare heart disease approved by FDA

The U.S. Food and Drug Administration has approved a drug developed at Stanford Medicine that offers hope to people diagnosed with a rare cardiovascular disease, transthyretin amyloid cardiomyopathy, or ATTR-CM.

Medications

First new treatment for asthma attacks in 50 years

An injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further treatment by 30%. The findings, published in The Lancet Respiratory Medicine, ...

Medications

Gold beats platinum for chemo drugs in new lab study

A new gold-based drug can slow tumor growth in animals by 82% and target cancers more selectively than standard chemotherapy drugs, according to a study by Australian and Indian researchers.